DEVELOPMENT PHARMACEUTICAL DRUGS

Brand Owner (click to sort) Address Description
RCC RCC Ltd. Zelgliweg 1 CH-4452 Itingen Switzerland Development of pharmaceutical drugs, not including dietary supplements, and chemical and agricultural products, namely, agrochemical, life science and biocide products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; research of new products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research, development and analysis for new medicine for humans provided to research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products;
RCC LINKING SCIENCE TO PROGRESS RCC Ltd. Zelgliweg 1 CH-4452 Itingen Switzerland Development of pharmaceutical drugs, not including dietary supplements, and chemical and agricultural products, namely, agrochemical, life science and biocide products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; research of new products for research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products; scientific research, development and analysis for new medicine for humans provided to research-based companies doing business in the field of production and development of pharmaceutical, medical and biotechnologic products;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs. More particularly, the invention relates to novel prodrugs of antimuscarinic agents with superior pharmacokinetic properties compared to existing drugs such as oxybutynin and tolterodine, methods for their preparation, pharmaceutical compositions containing them, a method of using said compounds and compositions for the treatment of urinary incontinence, gastrointestinal hyperactivity (irritable bowel syndrome) and other smooth muscle contractile conditions.